Stress free therapy for COPD

Tetsuya Homma0 个研究点目标入组 20 人开始时间: 2022年1月13日最近更新: 2023年10月17日

试验速览

暂无简介。

•Research subjects (those who meet all of the following items)
•Have been diagnosed with COPD and are outpatient
•(2) COPD is a patient who falls under stage II or stage III in the GOLD classification.
•Patients with a CAT score of 10 points or higher and an mMRC of grade 1 or higher
•Patients whose general condition is stable
•Patients whose age at the time of obtaining consent is 40 to 80 years old

•Exclusion criteria
•Patients with a history of affecting the evaluation items (neurological disorders, osteoarthritis, etc.)
•Contraindications for physical therapy
•Users of implantable electronic devices (pacemakers, etc.), patients with heart disease, malignant tumor, tuberculous disease, or acute disease, those who are extremely debilitated, pregnant women or those who may become pregnant, perception / skin by atopy, etc. Persons with hypersensitivity, possible impaired blood flow, using metal implants, history of or suspected of having epilepsy.
•Others who are deemed inappropriate by the doctor.
•In the following cases, it is at the discretion of the doctor. Abnormal blood pressure, fever, or infectious disease, etc.
•Patients who cannot attach electrodes due to skin diseases, etc.
•Patients who changed or added the main drug therapy of COPD during the study period from the time of obtaining consent
•Those who the doctor in charge judges to be inappropriate for participation in the research
•Those who receive stress-free therapy on a daily basis

发起方

Tetsuya Homma